Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
PAP 248-286 (Prostatic acid phosphatase (248-286)) acetate is a biologically active peptide that acts as a semen-derived enhancer of viral infection (SEVI) factor. This peptide significantly increases HIV infection by enhancing virion attachment to target cells.
Biologically active peptide
Semen-derived enhancer of viral infection (SEVI) factor
Significantly increases HIV infection by enhancing virion attachment to target cells
Applications in COVID-19 anti-virus research
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
KCL-286 (C286) is an orally active and brain-penetrant retinoic acid receptor (RAR) β2 agonist (EC50 = 1.9 nM). It activates RARβ2 in injured neurons, inducing axonal regeneration and modulating neuroinflammation and extracellular matrix molecules. It can also modulate the expression of chondroitin sulfate proteoglycans (CSPGs) by neuronal secretion of decorin, promoting myelination and aiding axonal growth.
Targets RARβ2 with selectivity over RAR α and RAR γ.
Activates RARβ2 in injured neurons.
Induces axonal regeneration of spinal and sensory nerves.
Modulates neuroinflammation and extracellular matrix molecules.
Promotes myelination and aids axonal growth.
Suitable for research in spinal cord injury and traumatic nerve injury.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
KCL-286 (C286) is a potent, selective retinoic acid receptor beta-2 (RARβ2) agonist reported to be orally active and brain-penetrant (reported EC50 = 1.9 nM). It is intended for research use in in vitro and in vivo studies of retinoid signaling and neurological pharmacology. Characterization includes molecular formula C19H14N2O4, molecular weight 334.33 g·mol⁻1, and CAS 1952276-71-9.
Potent RARβ2 agonist (EC50 = 1.9 nM).
Orally active and brain-penetrant in reported studies.
Suitable for in vitro and in vivo pharmacology studies.
Characterized by molecular formula C19H14N2O4 and molecular weight 334.33 g·mol⁻1.
Supplied as a high-purity research reagent (≈98.9% reported purity).
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Also available in 1 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI). Purity 99.93%
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
PAP 248-286 (Prostatic acid phosphatase (248-286)) acetate is a biologically active peptide. It is a semen-derived enhancer of viral infection (SEVI) factor found in semen. This peptide significantly increases HIV infection by enhancing virion attachment to target cells.
Biologically active peptide
Semen-derived enhancer of viral infection (SEVI) factor
Enhances virion attachment to target cells, increasing HIV infection
Potential applications in COVID-19 anti-viral research
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
KCL-286 is an orally active and brain-penetrant retinoic acid receptor (RAR) β2 agonist. It targets RARβ2 with selectivity over RAR α and RAR γ, activating RARβ2 in injured neurons. This compound induces axonal regeneration of both spinal and sensory nerves through the inhibitory environment of the CNS, modulates neuroinflammation, and extracellular matrix molecules.
Orally active and brain-penetrant RAR β2 agonist
Selectivity for RARβ2 over RAR α and RAR γ
Activates RARβ2 in injured neurons
Induces axonal regeneration of spinal and sensory nerves
Modulates neuroinflammation and extracellular matrix molecules
Can modulate CSPG expression by neuronal secretion of decorin to promote myelination and axonal growth
Potential for research in spinal cord injury and traumatic nerve injury
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More